Brighton Jones’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALLO
Brighton Jones's ALLO Position: Q3 2026 in Review
Brighton Jones reduced its Allogene Therapeutics (ALLO) stake by 60% in Q3 2026, selling an estimated $37.4K and leaving 13,357 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.
Brighton Jones first reported a position in ALLO in Q1 2025 and has held it in 6 quarters since. The position peaked at $84.1K in Q1 2026. 158 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.
- Brighton Jones held 13,357 shares of Allogene Therapeutics worth $21.4K as of Q3 2026.
- Brighton Jones sold 19,645 Allogene Therapeutics shares in Q3 2026, an estimated $37.4K.
- Allogene Therapeutics made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1379 holding.
- Brighton Jones first reported a position in Allogene Therapeutics in Q1 2025 and has held it in 6 quarters since.
- Brighton Jones's Allogene Therapeutics position peaked at $84.1K in Q1 2026.
- 158 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.